ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 210 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,298,000 | -72.2% | 24,276 | -41.2% | 0.18% | -60.9% |
| Q4 2015 | $4,667,000 | -33.9% | 41,313 | -31.1% | 0.45% | -26.6% |
| Q3 2015 | $7,063,000 | -39.2% | 60,000 | -60.0% | 0.62% | -25.3% |
| Q2 2015 | $11,615,000 | -12.8% | 150,000 | -34.8% | 0.83% | -22.3% |
| Q1 2015 | $13,318,000 | -44.9% | 230,223 | -69.3% | 1.06% | -36.0% |
| Q4 2014 | $24,188,000 | -1.2% | 750,000 | -25.0% | 1.66% | -1.7% |
| Q3 2014 | $24,470,000 | +7.4% | 1,000,000 | -22.2% | 1.69% | +41.0% |
| Q2 2014 | $22,783,000 | -17.2% | 1,285,000 | -6.5% | 1.20% | +12.7% |
| Q1 2014 | $27,514,000 | +13.2% | 1,375,000 | -5.1% | 1.06% | +2.3% |
| Q4 2013 | $24,314,000 | +34.7% | 1,449,000 | -14.8% | 1.04% | +14.8% |
| Q3 2013 | $18,054,000 | +68.7% | 1,700,000 | -11.2% | 0.91% | +51.3% |
| Q2 2013 | $10,705,000 | – | 1,915,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |